8 results on '"Nghiem Duc Thuan"'
Search Results
2. Validation of a Highly Sensitive qPCR Assay for the Detection of Plasma Cell-Free Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma Diagnosis
- Author
-
Vu Nguyen Quynh Anh BA, Nguyen Van Ba MD, PhD, Do Tram Anh MD, Nguyen Dinh Ung MD, Nguyen Hoang Hiep PhD, Vu Thi Ly BA, Dinh Thi Thu Hang PhD, Bui Tien Sy MD, PhD, Hoang Dao Chinh MD, Le Minh Ky MD, PhD, Vu Truong Phong MD, PhD, Nguyen Kim Luu MD, PhD, Nguyen Thanh Trung BA, Ho Anh Son MD, PhD, Hoang Van Luong MD, PhD, Nghiem Duc Thuan MD, PhD, Ngo Thanh Tung MD, PhD, and Ho Huu Tho MD, PhD
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Quantification of plasma cell-free Epstein Barr virus DNA (cf EBV DNA) has been suggested as a promising liquid biopsy assay for screening and early detection of nasopharyngeal carcinoma (NPC). However, the diagnostic value of this assay is currently not known in the population of Vietnam, one of the countries which contributed the most to the NPC cases. Herein, we have reported a highly sensitive quantitative polymerase chain reaction (qPCR)-based assay targeting cf EBV DNA for the detection of NPC. A standard curve with linear regression, R 2 = 0.9961 (range: 25-150 000 copies/mL) and a detection limit of 25 copies/mL were obtained using an EBV standard panel provided by the Chinese University of Hong Kong. The clinical performance of this assay was assessed using plasma samples obtained from 261 Vietnamese individuals. The optimized qPCR assay detected cf EBV DNA in plasma with a sensitivity of 97.4% and a specificity of 98.2%. The absolute quantitative results of pretreatment cf EBV DNA and patient overall clinical stages were statistically correlated ( P < .05). In summary, the remarkably high sensitivity and specificity of our optimized qPCR assay strongly supports the wide use of cf EBV DNA quantification as a routine noninvasive method in early diagnosis and management of patients with NPC.
- Published
- 2020
- Full Text
- View/download PDF
3. Maternal Vaginal Colonization and Extended-Spectrum Beta-Lactamase-Producing Bacteria in Vietnamese Pregnant Women
- Author
-
Nguyen Thanh Viet, Vu Van Du, Nghiem Duc Thuan, Hoang Van Tong, Nguyen Linh Toan, Can Van Mao, Nguyen Van Tuan, Srinivas Reddy Pallerla, Dennis Nurjadi, Thirumalaisamy P. Velavan, and Ho Anh Son
- Subjects
pregnant women ,Enterobacterales ,antimicrobial resistance ,Vietnam ,extended-spectrum beta-lactamase ,Escherichia coli ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) resistance to commonly prescribed drugs is increasing in Vietnam. During pregnancy, ESBL-E may predispose women to reproductive tract infections and increases the risk for neonatal morbidity. Vaginal colonization and infections by Escherichia coli and Klebsiella pneumoniae are seldom studied in Vietnam. In this study, we investigated ESBL-producing Enterobacterales in the birth canal of pregnant women. Between 2016 and 2020, vaginal swabs were collected from 3104 pregnant women (mean gestational age of 31 weeks) and inoculated onto MacConkey agar plates. Colonies were subjected to direct identification and antimicrobial susceptibility testing using the VITEK®-2 automated compact system and disk diffusion. ESBL production was determined phenotypically. E. coli, Klebsiella species were identified in 30% (918/3104) of the vaginal swabs, with E. coli being the most common (73%; 667/918). ESBL-production was detected in 47% (432/918) of Enterobacterales, with frequent multidrug-resistant phenotype. The overall prevalence of carbapenem resistance was low (8%). Over 20% of Klebsiella spp. were carbapenem-resistant. Pregnant women had a high prevalence of colonization and may transmit ESBL-E to neonates at birth, an important risk factor to be considered. The high rate of ESBL-producers and carbapenem resistance in Enterobacterales in Vietnam emphasizes the need for consequent surveillance and access to molecular typing.
- Published
- 2021
- Full Text
- View/download PDF
4. Relationships of BRAF V600E Gene Mutation With Some Immunohistochemical Markers and Recurrence Rate in Patients With Thyroid Carcinoma.
- Author
-
Bui Dang Minh, Tri, Nghiem Duc, Thuan, Phan Nguyen Thanh, Van, Dinh Le, Tuan, Duc Tong, Minh, Hoang Nguyen, Trung, Tuan, Anh Le, Xuan Nguyen, Kien, Tran Viet, Tien, Ba Ta, Thang, Tien Nguyen, Son, Anh Vu, Hai, Van Nguyen, Ba, Nguyen Thi Ngoc, Dung, Tran Quoc, Viet, and Bui Duc, Thanh
- Subjects
- *
BIOMARKERS , *MILITARY hospitals , *CYCLOOXYGENASE 2 , *GENETIC mutation , *CONFIDENCE intervals , *THYROID gland tumors , *IMMUNOHISTOCHEMISTRY , *NONSTEROIDAL anti-inflammatory agents , *CANCER relapse , *FISHER exact test , *CANCER patients , *T-test (Statistics) , *TRANSFERASES , *CHI-squared test , *DESCRIPTIVE statistics , *POLYMERASE chain reaction , *ODDS ratio , *LONGITUDINAL method - Abstract
Background: The B-type rafkinase (BRAF) V600E gene mutation plays an important role in the pathogenesis, diagnosis, and prognosis of thyroid carcinoma. This study was conducted to investigate the rate of the BRAF V600E mutation, the relationships between the BRAF V600E gene mutation and some immunohistochemical markers, and recurrence rate in patients with differentiated thyroid cancer. Method: The study was conducted by a descriptive and longitudinal follow-up method on 102 thyroid carcinoma patients at 103 Military Hospital, Hanoi, Vietnam. All patients were identified with the BRAF V600E gene mutation by real-time polymerase chain reaction. Results: The rate of BRAF V600E gene mutation in patients with thyroid cancer was 60.8%. Patients with BRAF V600E gene mutation had a significantly higher rate of positive cyclooxygenase 2 (COX-2) and Ki67 markers than those without the mutation (COX-2: odds ratio [OR] = 2.93; 95% confidence interval [CI] = 1.27-6.74, P =.011; Ki67: OR = 3.41; 95% CI = 1.31-8.88, P =.01). A statistically significant relationship was identified between the rate of BRAF V600E mutation and the rate of positive Hector Battifora mesothelial 1 (HBME-1) (B = −1.040; P =.037) and COX-2 (B = −1.123; P =.023) markers. The recurrence rate in patients with BRAF V600E gene mutation was significantly higher than that in those without the mutation (P =.007). The mean of the recurrence time of patients with BRAF V600E mutation was significantly lower than that in those without the mutation (P =.011). Conclusions: A high prevalence of BRAF V600E gene mutation was found in thyroid carcinoma patients. The rates of positive HBME-1, COX-2, and Ki67 markers were significantly correlated to BRAF V600E gene mutation. Patients with BRAF V600E gene mutation showed a significantly higher relapse rate and earlier relapse time than those without the mutation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Maternal Vaginal Colonization and Extended-Spectrum Beta-Lactamase-Producing Bacteria in Vietnamese Pregnant Women
- Author
-
Vu Van Du, Nguyen Van Tuan, Hoang Van Tong, Can Van Mao, Nghiem Duc Thuan, Dennis Nurjadi, Ho Anh Son, Nguyen Thanh Viet, Thirumalaisamy P. Velavan, Srinivas Reddy Pallerla, and Nguyen Linh Toan
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Klebsiella pneumoniae ,medicine.medical_treatment ,030106 microbiology ,extended-spectrum beta-lactamase ,carbapenem resistance ,RM1-950 ,Biochemistry ,Microbiology ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Antibiotic resistance ,Enterobacterales ,medicine ,Escherichia coli ,polycyclic compounds ,Pharmacology (medical) ,Colonization ,030212 general & internal medicine ,antimicrobial resistance ,General Pharmacology, Toxicology and Pharmaceutics ,Risk factor ,Pregnancy ,biology ,Obstetrics ,business.industry ,Gestational age ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,medicine.disease ,bacterial infections and mycoses ,Infectious Diseases ,chemistry ,Vietnam ,Beta-lactamase ,bacteria ,Therapeutics. Pharmacology ,MacConkey agar ,business ,pregnant women - Abstract
Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) resistance to commonly prescribed drugs is increasing in Vietnam. During pregnancy, ESBL-E may predispose women to reproductive tract infections and increases the risk for neonatal morbidity. Vaginal colonization and infections by Escherichia coli and Klebsiella pneumoniae are seldom studied in Vietnam. In this study, we investigated ESBL-producing Enterobacterales in the birth canal of pregnant women. Between 2016 and 2020, vaginal swabs were collected from 3104 pregnant women (mean gestational age of 31 weeks) and inoculated onto MacConkey agar plates. Colonies were subjected to direct identification and antimicrobial susceptibility testing using the VITEK®-2 automated compact system and disk diffusion. ESBL production was determined phenotypically. E. coli, Klebsiella species were identified in 30% (918/3104) of the vaginal swabs, with E. coli being the most common (73%, 667/918). ESBL-production was detected in 47% (432/918) of Enterobacterales, with frequent multidrug-resistant phenotype. The overall prevalence of carbapenem resistance was low (8%). Over 20% of Klebsiella spp. were carbapenem-resistant. Pregnant women had a high prevalence of colonization and may transmit ESBL-E to neonates at birth, an important risk factor to be considered. The high rate of ESBL-producers and carbapenem resistance in Enterobacterales in Vietnam emphasizes the need for consequent surveillance and access to molecular typing.
- Published
- 2021
- Full Text
- View/download PDF
6. Validation of a Highly Sensitive qPCR Assay for the Detection of Plasma Cell-Free Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma Diagnosis
- Author
-
Nghiem Duc Thuan, Hoang Van Luong, Ho Huu Tho, Vu Truong Phong, Vu Nguyen Quynh Anh, Nguyen Thanh Trung, Nguyen Kim Luu, Dinh Thi Thu Hang, Do Tram Anh, Bui Tien Sy, Hoang Dao Chinh, Vu Thi Ly, Nguyen Hoang Hiep, Nguyen Dinh Ung, Le Minh Ky, Ho Anh Son, Nguyen Van Ba, and Ngo Thanh Tung
- Subjects
0301 basic medicine ,Early detection ,cell-free Epstein-Barr virus DNA ,Plasma cell ,lcsh:RC254-282 ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Liquid biopsy ,liquid biopsy ,business.industry ,nasopharyngeal carcinoma ,Epstein-Barr virus DNA ,Hematology ,General Medicine ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Molecular biology ,Highly sensitive ,early detection of cancer ,Original Research Paper ,030104 developmental biology ,medicine.anatomical_structure ,Real-time polymerase chain reaction ,Oncology ,Nasopharyngeal carcinoma ,Vietnam ,030220 oncology & carcinogenesis ,quantitative PCR ,business - Abstract
Quantification of plasma cell-free Epstein Barr virus DNA (cf EBV DNA) has been suggested as a promising liquid biopsy assay for screening and early detection of nasopharyngeal carcinoma (NPC). However, the diagnostic value of this assay is currently not known in the population of Vietnam, one of the countries which contributed the most to the NPC cases. Herein, we have reported a highly sensitive quantitative polymerase chain reaction (qPCR)-based assay targeting cf EBV DNA for the detection of NPC. A standard curve with linear regression, R 2 = 0.9961 (range: 25-150 000 copies/mL) and a detection limit of 25 copies/mL were obtained using an EBV standard panel provided by the Chinese University of Hong Kong. The clinical performance of this assay was assessed using plasma samples obtained from 261 Vietnamese individuals. The optimized qPCR assay detected cf EBV DNA in plasma with a sensitivity of 97.4% and a specificity of 98.2%. The absolute quantitative results of pretreatment cf EBV DNA and patient overall clinical stages were statistically correlated ( P < .05). In summary, the remarkably high sensitivity and specificity of our optimized qPCR assay strongly supports the wide use of cf EBV DNA quantification as a routine noninvasive method in early diagnosis and management of patients with NPC.
- Published
- 2020
7. Influence of the Preparation Method on Some Characteristics of Alginate/Chitosan/Lovastatin Composites.
- Author
-
Nghiem, Duc-Thuan, Nguyen, Thuy-Chinh, Do, Minh-Thanh, Nguyen, Thi-Huyen, Lam Tran, Dai, Hoang, Tran-Dung, Le, Van-Quan, Vu, Quoc-Trung, Nguyen, Duy-Trinh, and Thai, Hoang
- Subjects
- *
ALGINIC acid , *LOVASTATIN , *BUFFER solutions , *PHARMACOKINETICS , *SODIUM alginate - Abstract
This study investigates the effects of direct and indirect dispersion methods for lovastatin solid dispersion (LSD) in alginate (AG)/chitosan (CS) composites on the characteristics and properties of the AG/CS/LSD composites. The preparation method significantly influences the structure, morphology, and LSD size distribution of the composites as well as the drug release of LSD from the samples. The differences in dispersion methods for LSD lead to differences in the interaction between the components, the structure, and the control drug release of LSD. Lovastatin was released from the samples containing LSD in two stages (a fast release stage and a slow release stage), and the drug release content prepared using the indirect method is lower than that prepared using the direct method in the same buffer solution. After 32 h of testing, the released LSD content from the indirect and direct LSD dispersion methods in pH 2 and pH 7.4 buffer solutions was 87–94% and 41–61%, respectively. Drug release kinetics from the above samples in solutions with different pH values was also set up. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. A simple method for detection of a novel coronavirus (SARS‐CoV‐2) using one‐step RT‐PCR followed by restriction fragment length polymorphism
- Author
-
Hoang Xuan Su, Trinh Thanh Hung, Le Thi Bao Quyen, Nghiem Duc Thuan, Le Bach Quang, Ho Anh Son, Do Quyet, Luong Thi Hoai Thuong, Tran Viet Tien, Nguyen Van Ba, Vu Thi Nga, Hoang Van Luong, Nguyen Tung Linh, Dinh Thi Thu Hang, Le Van Nam, and Nguyen Thai Son
- Subjects
China ,Short Communication ,viruses ,Short Communications ,EcoRI ,Biology ,medicine.disease_cause ,Sensitivity and Specificity ,Coronavirus Disease: SARS‐CoV‐2 ,03 medical and health sciences ,0302 clinical medicine ,Virology ,medicine ,Humans ,030212 general & internal medicine ,skin and connective tissue diseases ,Gene ,Phylogeny ,DNA Primers ,030304 developmental biology ,Coronavirus ,Gel electrophoresis ,0303 health sciences ,Clinical Laboratory Techniques ,SARS-CoV-2 ,fungi ,COVID-19 ,SARS‐CoV ,virus diseases ,Amplicon ,3. Good health ,body regions ,Restriction enzyme ,RT‐PCR‐RFLP ,Real-time polymerase chain reaction ,Infectious Diseases ,Severe acute respiratory syndrome-related coronavirus ,COVID-19 Nucleic Acid Testing ,biology.protein ,RNA, Viral ,Restriction fragment length polymorphism ,Polymorphism, Restriction Fragment Length - Abstract
Background A novel coronavirus associated with acute respiratory disease (named SARS‐CoV‐2) is recently identified in Wuhan city, China, spread rapidly worldwide. An early identification of this novel coronavirus by molecular tools is critical for surveillance and control of the epidemic outbreak. Objectives We aimed to establish a simple method for detection of SARS‐CoV‐2 in differentiating with SARS‐CoV. Study design Primers of our in‐house RT‐PCR assays were designed to target conserved regions of the RdRP gene and E gene, selected restriction enzymes EcoRI, Tsp45I and AluI to distinguish between SARS‐CoV‐2 and SARS‐CoV. Results and Discussions In this report, a 396 bp fragment of the RdRp gene and 345 bp fragment of the E gene were amplified by one‐step RT‐PCR. Enzyme Tsp45I cuts the RdRP amplified product of SARS‐CoV‐2 generating 3 fragments of 45, 154 and 197 bp, but it did not cut the amplicon of SARS‐CoV. In contrast, the amplified product of SARS‐CoV was digested with EcoRI producing 2 fragments of 76 and 320 bp, whereas, the amplicon of SARS‐CoV‐2 was undigested by Tsp45I help to distinguish clearly SARS‐CoV‐2 from SARS‐CoV on gel electrophoresis. In addition, AluI cut the amplicon of the E gene of SARS‐CoV‐2 generating 2 fragments of 248 and 97 bp without cutting to SARS‐CoV. Accuracy of assay was confirmed by sequencing and phylogenetic analysis. When evaluated on clinical samples showed a high sensitivity of 95%, specificity of our assay was 100% and clinical performance for detection of SARS‐CoV‐2 in comparison with other reference assays. In conclusion, the present study, we successfully developed a simple method for molecular detection of SARS‐CoV‐2 in differentiating with SARS‐CoV. This article is protected by copyright. All rights reserved.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.